Director, President, CEO and Director · ACTUATE THERAPEUTICS, INC. · Common Stock
Side
M
Value
—
Shares
272.1K
Price
—
Executed
Aug 14, 2026
Disclosed
Aug 14, 2026
Disclosure timeline0 days from execution to publication · legal deadline 2 business days
Aug 14 executedAug 14, 2026 disclosed
ACTU · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+13 / 25
No reported dollar value · 181.2% of prior position
Filing timing0 / 15
Disclosed 0 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Schmitt Daniel M filed this Form 4 reporting a option exercise of ACTU on Aug 14, 2026. It became public on Aug 14, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, President, CEO and Director
Schmitt Daniel Mcik:0001318470
Issuer
ACTUATE THERAPEUTICS, INC.cik:0001652935
Revision history · 0
No field has changed since this record was first ingested.
